Does OBINUTUZUMAB Cause Ejection fraction decreased? 16 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 16 reports of Ejection fraction decreased have been filed in association with OBINUTUZUMAB (Gazyva). This represents 0.1% of all adverse event reports for OBINUTUZUMAB.
16
Reports of Ejection fraction decreased with OBINUTUZUMAB
0.1%
of all OBINUTUZUMAB reports
0
Deaths
6
Hospitalizations
How Dangerous Is Ejection fraction decreased From OBINUTUZUMAB?
Of the 16 reports, 6 (37.5%) required hospitalization.
Is Ejection fraction decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OBINUTUZUMAB. However, 16 reports have been filed with the FAERS database.
What Other Side Effects Does OBINUTUZUMAB Cause?
Off label use (1,584)
Neutropenia (1,276)
Febrile neutropenia (955)
Covid-19 (942)
Pyrexia (920)
Thrombocytopenia (889)
Disease progression (831)
Infusion related reaction (789)
Pneumonia (662)
Anaemia (640)
What Other Drugs Cause Ejection fraction decreased?
SACUBITRIL\VALSARTAN (2,551)
TRASTUZUMAB (1,579)
DOXORUBICIN (834)
CYCLOPHOSPHAMIDE (754)
PERTUZUMAB (644)
DOCETAXEL (520)
PACLITAXEL (466)
BISOPROLOL (314)
RITUXIMAB (296)
CARVEDILOL (284)
Which OBINUTUZUMAB Alternatives Have Lower Ejection fraction decreased Risk?
OBINUTUZUMAB vs OCELLA
OBINUTUZUMAB vs OCRELIZUMAB
OBINUTUZUMAB vs OCRIPLASMIN
OBINUTUZUMAB vs OCTINOXATE\OCTISALATE\ZINC
OBINUTUZUMAB vs OCTINOXATE\OCTOCRYLENE